Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Contracts

Contracts

Group By Ticker
Sort By
Newest | Oldest
Read More
1 minute read
  • Contracts
  • General
  • News

Lucid Group Signs Battery Supply Agreement With Panasonic Energy

By Shivani Kumaresan
December 13, 12:13 PM
Lucid Group Inc (NASDAQ:LCID) and Panasonic (OTC:PCRFY) Group company Panasonic Energy signed multi-year agreements to supply batteries for the luxury electric…

LCID

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Trading Ideas

Takeda To Add Mid-Stage Autoimmune Disease Candidate For $4B

By Vandana Singh
December 13, 10:55 AM
Takeda Pharmaceutical Co Ltd (NYSE:TAK) will acquire NDI-034858 from Nimbus Therapeutics, an oral, selective allosteric tyrosine kinase 2 (TYK2) inhibitor for multiple…

TAK

Read More
1 minute read
  • Biotech
  • Contracts
  • General
  • Health Care
  • Large Cap
  • Movers
  • News
  • Penny Stocks
  • Small Cap
  • Trading Ideas

Wave Life Sciences Shares Move Higher On Therapeutic Pact With GSK Targeting Genetic Disorders

By Vandana Singh
December 13, 10:51 AM
Wave Life Sciences Ltd (NASDAQ:WVE) and GSK plc (NYSE:GSK) have announced a strategic collaboration to advance oligonucleotide therapeutics, including Wave’s preclinical RNA editing…

GSK

Read More
1 minute read
  • Contracts
  • News

Taboola Signs Exclusive, Multi-Year Deal With Time Out; Terms Not Disclosed

By Benzinga Newsdesk
December 13, 10:02 AM
 Taboola (NASDAQ:TBLA), a global leader in powering recommendations for the open web, today announced a new multi-year deal with Time Out, a global media and hospitality business that inspires and enables

TBLA

Read More
1 minute read
  • Contracts
  • FDA
  • News

Annogen Announces Research Project With Pfizer To Test Non-Coding Genetic Sequences

By Benzinga Newsdesk
December 13, 9:55 AM
Annogen will functionally annotate tens of thousands of disease-related non-coding sequence variants with the goal of aiding drug discovery Annogen, the Amsterdam based biotech company behind the SuRE™ technology

PFE

Read More
1 minute read
  • Contracts
  • News

A2Z Announces 30% Increased Advanced Smart Cart Order, 300 Smart Carts, From Leading Israeli Retailer, Yochananof

By Benzinga Newsdesk
December 13, 9:42 AM
A2Z Smart Technologies Corp. (NASDAQ:AZ) (TSXV:AZ), today announces that it has received an increased purchased order of 30% (300 smart carts) from a leading grocery chain M. YOCHANANOF AND SONS (1988)

AZ

Read More
1 minute read
  • Contracts
  • News

BK Technologies Receives $1.4M Purchase Order For BKR 5000 From Washington State Department Of Natural Resources

By Benzinga Newsdesk
December 13, 9:36 AM
BK Technologies Corporation (NYSE:BKTI) (the "Company" or "BK Technologies") today announced that it has received a purchase order valued at $1.4 million from the Washington State Department

BKTI

Read More
2 minute read
  • Contracts
  • Global
  • News

Reported Late Monday, IBM And Rapidus Form Strategic Partnership To Build Advanced Semiconductor Technology And Ecosystem In Japan

By Benzinga Newsdesk
December 13, 1:41 AM
Rapidus, a Newly-Formed Advanced Logic Foundry, Will Leverage IBM's Semiconductor R&D Leadership, Including 2 Nanometer Node Technology TOKYO, Dec. 12, 2022 /PRNewswire/ -- IBM

IBM

Read More
2 minute read
  • Contracts
  • News

Fluor Joint Venture Opens Medford Branch Of Boston Green Line Rail Extension Project

By Benzinga Newsdesk
December 12, 5:35 PM
Fluor Corporation (NYSE:FLR) announced today that its joint venture team Green Line Extension Constructors—comprised of Fluor, Balfour Beatty Infrastructure, Inc., Herzog Contracting Group and The Middlesex

FLR

Read More
2 minute read
  • Contracts
  • News

On December 8, 2022, Z33 Bio Inc. An Entity Controlled By Zura Entered Into The License, Development And Commercialization Agreement With Eli Lilly And Company

By Benzinga Newsdesk
December 12, 5:19 PM
As previously announced on June 16, 2022, JATT Acquisition Corp, a Cayman Islands exempted company (“JATT” or the “SPAC”) entered into a Business Combination Agreement (as it may be amended,

JATT

Posts pagination

Previous 1 … 303 304 305 … 384 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service